• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Expression of activated Akt in benign nevi, Spitz nevi and melanomas.活化型Akt在良性痣、Spitz痣和黑色素瘤中的表达。
J Cutan Pathol. 2007 Aug;34(8):593-6. doi: 10.1111/j.1600-0560.2006.00675.x.
2
Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.c-kit(CD117)在斯皮茨痣和恶性黑色素瘤中的表达。
J Cutan Pathol. 2006 Jan;33(1):33-7. doi: 10.1111/j.0303-6987.2006.00420.x.
3
Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study.Spitz痣中细胞周期蛋白D1的过表达:一项免疫组织化学研究。
Am J Dermatopathol. 1999 Apr;21(2):115-20. doi: 10.1097/00000372-199904000-00001.
4
Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis.斯皮茨痣和非典型斯皮茨痣/肿瘤:组织学和免疫组织化学分析
Mod Pathol. 2005 Feb;18(2):197-204. doi: 10.1038/modpathol.3800281.
5
Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.Cdc7在黑色素瘤、Spitz瘤和黑素细胞痣中的表达。
J Cutan Pathol. 2009 Apr;36(4):433-8. doi: 10.1111/j.1600-0560.2008.01077.x.
6
BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.BAP1和BRAFV600E在良性和恶性黑素细胞增殖中的表达
Hum Pathol. 2015 Feb;46(2):239-45. doi: 10.1016/j.humpath.2014.10.015. Epub 2014 Nov 4.
7
p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.p16 表达:儿童恶性黑色素瘤与 Spitz 痣的分化标志物。
J Am Acad Dermatol. 2011 Aug;65(2):357-363. doi: 10.1016/j.jaad.2010.07.031. Epub 2011 May 6.
8
S100A6 protein expression is different in Spitz nevi and melanomas.S100A6蛋白表达在Spitz痣和黑色素瘤中存在差异。
Mod Pathol. 2003 May;16(5):505-11. doi: 10.1097/01.MP.0000071128.67149.FD.
9
Expression of p15 in a spectrum of spitzoid melanocytic neoplasms.p15在一系列Spitz样黑素细胞肿瘤中的表达。
J Cutan Pathol. 2019 May;46(5):310-316. doi: 10.1111/cup.13424. Epub 2019 Feb 14.
10
The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions.c-Kit 在黑色素细胞病变免疫组织化学评估中的作用。
Eur J Histochem. 2011 Jun 7;55(2):e20. doi: 10.4081/ejh.2011.e20.

引用本文的文献

1
Melanocytic nevi and melanoma: unraveling a complex relationship.黑素细胞痣与黑色素瘤:解析复杂关系。
Oncogene. 2017 Oct 19;36(42):5771-5792. doi: 10.1038/onc.2017.189. Epub 2017 Jun 12.
2
Immune-phenotypical markers for the differential diagnosis of melanocytic lesions.用于黑素细胞性病变鉴别诊断的免疫表型标志物。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):9742-51. eCollection 2015.
3
mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.mTORC1 激活可阻断 BrafV600E 诱导的生长停滞,但不足以形成黑色素瘤。
Cancer Cell. 2015 Jan 12;27(1):41-56. doi: 10.1016/j.ccell.2014.11.014.
4
Navigating the therapeutic complexity of PI3K pathway inhibition in melanoma.在黑色素瘤中探索 PI3K 通路抑制的治疗复杂性。
Clin Cancer Res. 2013 Oct 1;19(19):5310-9. doi: 10.1158/1078-0432.CCR-13-0142.
5
MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and Bevacizumab.接受替西罗莫司和贝伐单抗联合靶向治疗的黑色素瘤中诱导的 microRNAs。
J Transl Med. 2013 Sep 18;11:218. doi: 10.1186/1479-5876-11-218.
6
Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma.PLX4032 选择性抑制 BRAF 治疗恶性黑色素瘤的疗效信号药效学特征。
Neoplasia. 2010 Aug;12(8):637-49. doi: 10.1593/neo.10414.
7
Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.Akt3与突变型V600E B-Raf协同作用,促进早期黑色素瘤的发展。
Cancer Res. 2008 May 1;68(9):3429-39. doi: 10.1158/0008-5472.CAN-07-5867.
8
Understanding signaling cascades in melanoma.了解黑色素瘤中的信号级联反应。
Photochem Photobiol. 2008 Mar-Apr;84(2):289-306. doi: 10.1111/j.1751-1097.2007.00254.x. Epub 2007 Dec 15.

本文引用的文献

1
The Spitzoid lesion: rethinking Spitz tumors, atypical variants, 'Spitzoid melanoma' and risk assessment.Spitzoid病变:重新审视Spitz肿瘤、非典型变体、“Spitzoid黑色素瘤”及风险评估
Mod Pathol. 2006 Feb;19 Suppl 2:S21-33. doi: 10.1038/modpathol.3800519.
2
Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.c-kit(CD117)在斯皮茨痣和恶性黑色素瘤中的表达。
J Cutan Pathol. 2006 Jan;33(1):33-7. doi: 10.1111/j.0303-6987.2006.00420.x.
3
hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.黑素细胞性病变中的hTERT表达:对石蜡包埋组织的免疫组织化学研究
J Cutan Pathol. 2005 Nov;32(10):680-4. doi: 10.1111/j.0303-6987.2005.00403.x.
4
Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome.活化型Akt和PTEN在恶性黑色素瘤中的表达:与临床结局的关系。
Am J Clin Pathol. 2005 Oct;124(4):528-36. doi: 10.1309/YT58WWMTA6YR1PRV.
5
Cytoplasmic and nuclear expression of survivin in melanocytic skin lesions.存活素在黑素细胞性皮肤病变中的细胞质和细胞核表达。
Arch Dermatol Res. 2005 Jul;297(1):26-30. doi: 10.1007/s00403-005-0572-x. Epub 2005 May 19.
6
Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases.Akt激活表达在黑色素瘤中的预后意义:292例临床病理研究
J Clin Oncol. 2005 Mar 1;23(7):1473-82. doi: 10.1200/JCO.2005.07.168.
7
Deregulated Akt3 activity promotes development of malignant melanoma.Akt3活性失调促进恶性黑色素瘤的发展。
Cancer Res. 2004 Oct 1;64(19):7002-10. doi: 10.1158/0008-5472.CAN-04-1399.
8
PI3K/Akt signalling pathway and cancer.PI3K/Akt信号通路与癌症
Cancer Treat Rev. 2004 Apr;30(2):193-204. doi: 10.1016/j.ctrv.2003.07.007.
9
Apoptosis and melanoma chemoresistance.细胞凋亡与黑色素瘤化疗耐药性。
Oncogene. 2003 May 19;22(20):3138-51. doi: 10.1038/sj.onc.1206454.
10
Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression.黑色素瘤中Akt/蛋白激酶B的组成性激活导致核因子-κB上调和肿瘤进展。
Cancer Res. 2002 Dec 15;62(24):7335-42.

活化型Akt在良性痣、Spitz痣和黑色素瘤中的表达。

Expression of activated Akt in benign nevi, Spitz nevi and melanomas.

作者信息

Kantrow Sara M, Boyd Alan S, Ellis Darrel L, Nanney Lillian B, Richmond Ann, Shyr Yu, Robbins Jason B

机构信息

Department of Medicine (Dermatology), Vanderbilt University Nashville, TN, USA.

出版信息

J Cutan Pathol. 2007 Aug;34(8):593-6. doi: 10.1111/j.1600-0560.2006.00675.x.

DOI:10.1111/j.1600-0560.2006.00675.x
PMID:17640227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2665272/
Abstract

BACKGROUND

Activated Akt expression (p-Akt) is reportedly increased in many melanomas as compared with benign nevi. The purpose of this study was to evaluate and compare p-Akt immunohistological staining in benign nevi, Spitz nevi and primary melanomas.

METHODS

Immunostaining for phosphorylated Akt was performed in 41 melanocytic lesions previously classified as benign intradermal nevus (14 lesions), Spitz nevus (9 lesions) or melanoma (18 lesions). Lesions were graded for intensity of p-Akt staining by two independent observers (0, no staining; 1, slightly positive; 2, moderately positive; 3, highly positive). Scores were averaged, and statistical analyses were performed.

RESULTS

Benign nevi showed less staining (mean score 1.18) compared with Spitz nevi (mean score 2.11) and melanomas (mean score 2.19). This difference was statistically significant between benign nevi and melanomas (p = 0.0047) and benign nevi and Spitz nevi (p = 0.0271). No statistical difference was detected in staining between Spitz nevi and melanomas (p = 0.8309).

CONCLUSIONS

Activated Akt expression is increased in Spitz nevi and melanomas as compared with benign intradermal nevi, but is unlikely to prove useful in differentiating between the former.

摘要

背景

据报道,与良性痣相比,许多黑色素瘤中活化的Akt表达(p-Akt)增加。本研究的目的是评估和比较良性痣、Spitz痣和原发性黑色素瘤中p-Akt的免疫组织化学染色。

方法

对41个先前分类为良性真皮内痣(14个病变)、Spitz痣(9个病变)或黑色素瘤(18个病变)的黑素细胞病变进行磷酸化Akt的免疫染色。由两名独立观察者对病变的p-Akt染色强度进行分级(0,无染色;1,弱阳性;2,中度阳性;3,强阳性)。对分数进行平均,并进行统计分析。

结果

与Spitz痣(平均分数2.11)和黑色素瘤(平均分数2.19)相比,良性痣的染色较少(平均分数1.18)。良性痣与黑色素瘤之间(p = 0.0047)以及良性痣与Spitz痣之间(p = 0.0271)的这种差异具有统计学意义。Spitz痣和黑色素瘤之间的染色未检测到统计学差异(p = 0.8309)。

结论

与良性真皮内痣相比,Spitz痣和黑色素瘤中活化的Akt表达增加,但不太可能有助于区分两者。